Callahan, et al: “The Discovery of GSK3227634: A Potent Inhaled Inhibitor of the KEAP1/NRF2 Protein-Protein Interaction for the Treatment of COPD”, J Med Chem. 2026
Callahan, et al: “The Discovery of GSK3227634: A Potent Inhaled Inhibitor of the KEAP1/NRF2 Protein-Protein Interaction for the Treatment of COPD”, J. Med Chem. 2026
https://pubs.acs.org/jmcmar/article/69/17/20859/5256079/The-Discovery-of-GSK3227634-A-Potent-Inhaled